Shozeb

@shozebhaider.bsky.social

Professor of Biophysics, Drug Discovery, Photographer, Traveller and a Cultural succupus.

How I wish Prof Struther Arnott was alive to tell the story about the DNA structure saga. He was privy to the drama played out. It was Randall who pushed Franklin out of KCL taking DNA research away from her. Franklin herself showed a low res image in a seminar to Watson.

My dear friend Keshav Desiraju. passed away this day, four years ago. He was the force behind the Mental Health Act in India and the initiator of all the gutka bans that have/have not been implemented. You’re dearly missed my friend.

Bild

In case you're a researcher keen to flee to the UK. 'A £54 million “global talent fund” will cover relocation and research costs for “world-class” researchers and their teams to move to the UK....the fund will also cover full visa costs.' 1/2

UK finally unveils £54 million global talent scheme

Much-anticipated package for recruiting foreign researchers follows similar moves by France and the European Union to snap up US scientists

timeshighereducation.com

Our first foray into Class C beta-lactamases - explaining how #antibiotic ceftazidime is broken down more easily by AmpC variants. #AMR #enzymes #compchem Great work by @andersonlimaaa.bsky.social, as @royalsociety.org fellow ACS Catalysis (Open Access): pubs.acs.org/doi/10.1021/...

Insights into the Enhanced Ceftazidime Hydrolysis by Ent385 AmpC β-Lactamase from Multiscale Simulations

The emergence of multidrug-resistant bacteria poses a significant threat to public health. Particularly, they are becoming increasingly resistant to β-lactam antibiotics, which are one of the most important drug classes for the treatment of bacterial infections. Ceftazidime-avibactam has shown promising activity against highly drug-resistant bacteria, including carbapenem-resistant Enterobacterales. However, an Ala294-Pro295 deletion in the Class CE. cloacaeAmpC β-lactamase can confer reduced susceptibility to these agents. In this study, we investigated the molecular mechanisms underlying the enhanced hydrolysis of ceftazidime by E. cloacae Ent385 AmpC β-lactamase with the deletion using quantum mechanics/molecular mechanics (QM/MM) simulations. We used constant pH molecular dynamics simulations of the β-lactamase-ceftazidime acyl-enzyme complex to verify the likely protonation states, confirming Tyr150 primarily exists as a tyrosinate. We then used QM/MM (DFTB2/ff14SB) umbrella sampling to calculate the reaction-free energy barriers (Δ‡G) for the deacylation step of cephalosporin hydrolysis. This reveals that Tyr150 (rather than the substrate) acts as the base. Importantly, the difference in Δ‡G between the canonical E. cloacae AmpC (P99) and the Ent385 variant with Ala294-Pro295 reinserted, on the one hand, and the Ent385 variant, on the other, was in very good agreement with the difference deduced from experimental kinetic data. Detailed analysis of the transition state ensembles, alongside additional simulations, shows that the Ala294-Pro295 deletion allows the entrance of an additional water molecule that helps stabilize the tetrahedral intermediate. Overall, our QM/MM simulations provide valuable insights into the reaction mechanism and reasons for enhanced ceftazidime breakdown. The protocol used in this study successfully captures the kinetic differences observed among the studied variants. This approach can be employed to investigate other Class C β-lactamase variants with similar features, providing insights into their mechanisms and potential contributions to reduced susceptibility to antibiotic treatments.

pubs.acs.org